Global Health Goals at Risk: WHO Report Reveals Stalled Progress on Key Diseases

Introduction: A Global Health Check-Up

Every year, the World Health Organization (WHO) releases its global health statistics report, a comprehensive assessment of worldwide health trends and progress toward the ambitious targets set in 2015 as part of the United Nations' Sustainable Development Goals (SDGs). Think of it as a global health report card—grading our collective efforts to improve well-being by 2030. The 2026 edition, published this week, delivers a sobering verdict: while some improvements are visible, progress remains uneven and alarmingly slow. As the deadline draws nearer, the world appears on track to miss many of its health-related goals.

Global Health Goals at Risk: WHO Report Reveals Stalled Progress on Key Diseases — Source: www.technologyreview.com

HIV: Stalled Momentum in Ending the Epidemic

Before the SDGs, the Millennium Development Goals set a target to halt and reverse the spread of HIV—a goal achieved ahead of schedule by 2015. That success fueled optimism that the AIDS epidemic could be ended by 2030. Yet the latest data paints a less hopeful picture. In 2024, an estimated 1.3 million new HIV infections occurred worldwide. Although this figure represents a 40% decline from 2010 levels, it still means over a million people acquired the virus in a single year. The SDG target aims for a 90% reduction in HIV incidence by 2030—a goal that now seems out of reach given current trends.

Tuberculosis: A Disease That Refuses to Retreat

The situation for tuberculosis (TB) is even more concerning. TB ranks as the 10th leading cause of death globally, according to the WHO. The SDG target was to reduce TB cases by 80% between 2015 and 2030. However, by 2024, cases had fallen by only 12%—a mere fraction of the required progress. Regional disparities are stark: while some areas have seen declines, the Americas recorded a 13% increase in TB cases during the same period. Without a dramatic acceleration in prevention and treatment efforts, the 2030 target will be missed.

Why TB Progress Is So Slow

Factors include underfunding of TB programs, the rise of drug-resistant strains, and the impact of the COVID-19 pandemic, which disrupted diagnosis and treatment services. Many countries still lack access to rapid diagnostics and effective therapies, leaving millions without care.

Malaria: Resurgence Fueled by Resistance and Climate Change

Malaria, a mosquito-borne disease with a 7% fatality rate, was another area of optimism: the European region has been malaria-free since 2015. Yet globally, the fight against malaria is backsliding. The SDG target was a 90% reduction in malaria incidence by 2030 from 2015 levels. Instead, 2024 saw an estimated 282 million cases worldwide, representing an 8.5% increase in incidence rates. Africa, which bears the heaviest burden, is experiencing especially troubling trends.

Challenges in Malaria Control

Two major threats are undermining progress. First, antimalarial drug resistance has been confirmed or suspected in eight African countries, according to a separate WHO report, rendering standard treatments less effective. Second, insecticide-resistant mosquitoes are now present in nine African nations, reducing the efficacy of bed nets and indoor spraying. Climate change compounds these issues by expanding mosquito habitats, potentially making transmission seasons longer and more intense.

Child Malnutrition: The Crisis of Wasting

Children are also falling through the cracks. Malnutrition—specifically wasting, where children become dangerously thin for their height—remains a critical problem. As of 2024, the global prevalence of wasting in children under five was 6.6%, which translates to a staggering 42.8 million children suffering from acute malnutrition. These children are literally wasting away, with their bodies consuming muscle and fat to survive. The SDG target aims to eliminate all forms of malnutrition, but current trends show insufficient progress, especially in sub-Saharan Africa and South Asia.

Conclusion: A Call for Renewed Commitment

The 2026 WHO report is a stark reminder that ambition alone cannot achieve health goals. While some gains have been made—HIV incidence down 40% from 2010, and TB cases reduced by 12% since 2015—the pace is far too slow. The original targets, set with optimism in 2015, now appear overly ambitious for many diseases. Without a massive scale-up of funding, innovation, and political will, the world will miss its 2030 health targets. As the report card shows, it’s time to move from complacency to action before it’s too late.